Completed NA INTERVENTIONAL 4-arm NCT00974753

Prophylactic Ketorolac Post Epiretinal Membrane Surgery

A Placebo-controlled, Randomized, Clinical Trial of Prophylactic Ketorolac 0.5% in Patients Undergoing Pars Plana Vitrectomy and Phacovitrectomy Epiretinal Membrane Peel Surgery: Assessing Macular Volume With Spectral-domain OCT

Sponsor: Queen's University

Conditions Macular Edema

Interventions Ketorolac 0.5% Saline drops

Updated 7 times since 2017 Last updated: Jan 12, 2016 Started: Mar 31, 2010 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00974753, this NA trial focuses on Macular Edema and remains completed. Sponsored by Queen's University, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Completed NA
Apr 2025 — Jun 2025 [monthly]

Completed NA
Sep 2024 — Apr 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Queen's University

Data source: Queen's University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kingston, Canada